Immuno-positron emission tomography (immunoPET) is a paradigm-shifting molecular
imaging modality combining the superior targeting specificity of monoclonal antibody (mAb) …

Abstract Background The radiometal gallium-68 (68Ga) is increasingly used in diagnostic
positron emission tomography (PET), with 68Ga-labeled radiopharmaceuticals developed …

Nuclear medicine is expected to make major advances in cancer diagnosis and therapy;
tumor-targeted radiopharmaceuticals preferentially eradicate tumors while causing minimal …

The detection of prostate cancer lesions by PET imaging of the prostate-specific membrane
antigen (PSMA) has gained highest clinical impact during the last years. 68Ga-labelled Glu …

Molecular imaging is the visualization, characterization, and measurement of biological
processes at the molecular and cellular levels in humans and other living systems …

Purpose Prostate-specific membrane antigen (PSMA) is expressed ubiquitously on the
membrane of most prostate tumors and its metastasis. While PET/CT using 11 C-choline …

Positron Emission Tomography (PET) experienced accelerated development and has
become an established method for medical research and clinical routine diagnostics on …

The contribution of 68Ga to the promotion and expansion of clinical research and routine
positron emission tomography (PET) for earlier better diagnostics and individualized …

The aim of these guidelines is to assist nuclear medicine physicians in recommending,
performing, reporting and interpreting the results of somatostatin (SST) receptor PET/CT …

Radiolabeled somatostatin analogs represent valuable tools for both in vivo diagnosis and
therapy of neuroendocrine tumors (NETs) because of the frequent tumoral overexpression of …